“ When the already-high levels of motivation and engagement among our employees were combined with the additional sense of purpose and urgency that COVID-19 has brought, our… ”
In Conversation
“ The pandemic, while tragic, has provided Korean bio-ventures with opportunities to develop and mature ”
“ In Benelux there is probably not a single person who has never been in contact with a BD solution. Mathematically, we touch more than 20 patients… ”
“ Finding the unique algorithm specifically engineered for pre-menopausal Asian [breast cancer] patients was an important step for us and was crucial in confirming the accuracy of… ”
Philippe de Pougnadoresse – Country President & General Manager Pharma, Novartis Belgium & Luxembourg
“ Here in Belgium, we have a perfect match between country and company, as both thrive on innovation ”
“ Recently we have patented the new MMCR technology (for multi-layer microparticle controlled-release system) enabling us to convert a well-established API from tablets to syrup, with the… ”
“ I predict that some of the changes in consumer preferences will remain after the pandemic ends. Therefore, we as an organisation need to be ready for… ”
“ It is very important that we have a collaboration with pharmaceutical companies so that we can act as a bridge between patients and the developers of… ”
“ We have several agreements in place ... We hope that this combined effort will lead to a number of successful COVID-vaccines that will use our adjuvant… ”
“ We have many programs currently in Phase III development. All these medicines are potentially transformative in nature. These are not ‘me too’ drugs that aim to… ”
“ My priority leading LEO Pharma Inc. in the US is attracting, developing and retaining members of our team. We have focused on building a company culture… ”
“ We want to combine the agility of a biotech with the experience of a Big Pharma company ”